These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 20641320

  • 21. 124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results.
    Zou P, Povoski SP, Hall NC, Carlton MM, Hinkle GH, Xu RX, Mojzisik CM, Johnson MA, Knopp MV, Martin EW, Sun D.
    World J Surg Oncol; 2010 Aug 06; 8():65. PubMed ID: 20691066
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct.
    Pavlinkova G, Colcher D, Booth BJ, Goel A, Batra SK.
    Cancer Immunol Immunother; 2000 Jul 06; 49(4-5):267-75. PubMed ID: 10941910
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Biodistribution and dosimetry of In-111/Y-90-HuCC49ΔCh2 (IDEC-159) in patients with metastatic colorectal adenocarcinoma.
    Shen S, Forero A, Meredith RF, LoBuglio AF.
    Cancer Biother Radiopharm; 2011 Feb 06; 26(1):127-33. PubMed ID: 21355784
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49.
    Chauhan SC, Jain M, Moore ED, Wittel UA, Li J, Gwilt PR, Colcher D, Batra SK.
    Eur J Nucl Med Mol Imaging; 2005 Mar 06; 32(3):264-73. PubMed ID: 15791435
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    The MICAD Research Team.
    ; 2004 Mar 06. PubMed ID: 20641447
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
    Molinolo A, Simpson JF, Thor A, Schlom J.
    Cancer Res; 1990 Feb 15; 50(4):1291-8. PubMed ID: 2297774
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49.
    Kashmiri SV, Shu L, Padlan EA, Milenic DE, Schlom J, Hand PH.
    Hybridoma; 1995 Oct 15; 14(5):461-73. PubMed ID: 8575795
    [Abstract] [Full Text] [Related]

  • 35. Biologic properties of a CH2 domain-deleted recombinant immunoglobulin.
    Slavin-Chiorini DC, Horan Hand PH, Kashmiri SV, Calvo B, Zaremba S, Schlom J.
    Int J Cancer; 1993 Jan 02; 53(1):97-103. PubMed ID: 8416208
    [Abstract] [Full Text] [Related]

  • 36.
    Chopra A.
    ; 2004 Jan 02. PubMed ID: 22049575
    [Abstract] [Full Text] [Related]

  • 37.
    Chopra A.
    ; 2004 Jan 02. PubMed ID: 22049573
    [Abstract] [Full Text] [Related]

  • 38.
    Chopra A.
    ; 2004 Jan 02. PubMed ID: 21834179
    [Abstract] [Full Text] [Related]

  • 39.
    Chopra A.
    ; 2004 Jan 02. PubMed ID: 21834181
    [Abstract] [Full Text] [Related]

  • 40.
    Chopra A.
    ; 2004 Jan 02. PubMed ID: 21834182
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.